Fidelity Investments’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.1K Sell
2,655
-8,124
-75% -$30.4K ﹤0.01% 4861
2026
Q2
$33.2K Buy
10,779
+7,391
+218% +$25.1K ﹤0.01% 4480
2026
Q1
$14.2K Sell
3,388
-479
-12% -$2K ﹤0.01% 4657
2025
Q4
$16.7K Buy
3,867
+3,529
+1,044% +$13.5K ﹤0.01% 4542
2025
Q3
$1.47K Buy
338
+316
+1,436% +$1.42K ﹤0.01% 4974
2025
Q2
$102 Buy
+22
New +$87 ﹤0.01% 5137

Other funds holding SBC

Fidelity Investments's SBC Position: Q3 2026 in Review

Fidelity Investments reduced its SBC Medical Group (SBC) stake by 75% in Q3 2026, selling an estimated $30.4K and leaving 2,655 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4861.

Fidelity Investments first reported a position in SBC in Q2 2025 and has held it in 6 quarters since. The position peaked at $33.2K in Q2 2026. 69 funds tracked by Wall St. Rank hold SBC as of Q3 2026.

  • Fidelity Investments held 2,655 shares of SBC Medical Group worth $13.1K as of Q3 2026.
  • Fidelity Investments sold 8,124 SBC Medical Group shares in Q3 2026, an estimated $30.4K.
  • SBC Medical Group made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #4861 holding.
  • Fidelity Investments first reported a position in SBC Medical Group in Q2 2025 and has held it in 6 quarters since.
  • Fidelity Investments's SBC Medical Group position peaked at $33.2K in Q2 2026.
  • 69 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.